Tc-99m imaging in thyroidectomized differentiated thyroid cancer patients immediately before I-131 treatment
CJ Tsai, CY Cheng, DHY Shen, SJ Kuo… - Nuclear medicine …, 2016 - journals.lww.com
Purpose The aim of this study was to evaluate the clinical role of technetium-99m
pertechnetate (Tc-99m) imaging in thyroidectomized differentiated thyroid cancer patients …
pertechnetate (Tc-99m) imaging in thyroidectomized differentiated thyroid cancer patients …
A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for …
AF Leger, M Pellan, F Dagousset… - The British Journal of …, 2005 - academic.oup.com
Thyroid stunning is usually defined as the inhibition or suppression of iodide trapping by
remnant thyroid tissue or by functioning metastases following a diagnostic dose of 131I. The …
remnant thyroid tissue or by functioning metastases following a diagnostic dose of 131I. The …
A comparison between diagnostic I-123 and posttherapy I-131 scans in the detection of remnant and locoregional thyroid disease
DL Thomas, Y Menda, D Bushnell - Clinical nuclear medicine, 2009 - journals.lww.com
Aim of Study: The aim of this study was to compare pretherapy diagnostic I-123 scans with 7-
day posttherapy I-131 scans days in detecting remnant thyroid disease as well as …
day posttherapy I-131 scans days in detecting remnant thyroid disease as well as …
Comparing pre-therapeutic 124I and 131I uptake tests with intra-therapeutic 131I uptake in benign thyroid disorders
F Gühne, C Kühnel, M Freesmeyer - Endocrine, 2017 - Springer
Abstract Purpose 124 I-PET/CT can be used for pre-therapeutic assessment of radioactive
iodine uptake in benign thyroid disorders, however systematic comparisons with intra …
iodine uptake in benign thyroid disorders, however systematic comparisons with intra …
I-131 in the management of differentiated thyroid cancer–an update on current recommendations and practices
U Ravishankar, S Pande, N Savita - Apollo Medicine, 2009 - Elsevier
I-131 is an established diagnostic and therapeutic modality for patients with functioning
residual disease after surgery, and is widely used for remnant ablation and treating …
residual disease after surgery, and is widely used for remnant ablation and treating …
Initial radioiodine administration: when to use it and how to select the dose
G Esposito - Endocrinology and Metabolism Clinics, 2014 - endo.theclinics.com
Radioactive iodine has been used in the management of thyroid cancer since the early
1940s. In 1940, Hamilton and colleagues 1 described the first case of uptake of radioactive …
1940s. In 1940, Hamilton and colleagues 1 described the first case of uptake of radioactive …
Diagnostic 123I and 131I activities and radioiodine therapy
B Meller, K Von Hof, E Genina… - Nuklearmedizin …, 2005 - thieme-connect.com
Aim: Urinary iodine excretion (UIE) provides information about iodine supply and release. In
the present study we investigated effects of the application of different radioiodine isotopes …
the present study we investigated effects of the application of different radioiodine isotopes …
Different strategies to overcome the effect of carbimazole on high‐and low‐dose radioiodine therapy: results from continuous dose–effect models
MA Walter, C Schindler, M Christ‐Crain… - European journal of …, 2009 - Wiley Online Library
Background Until now, it remains elusive which strategy–antithyroid drug withdrawal or
increased radioiodine target doses–should be preferred to avoid the detrimental effect of …
increased radioiodine target doses–should be preferred to avoid the detrimental effect of …
Radioiodine whole-body imaging
FB Atkins, D Van Nostrand - Thyroid cancer: a comprehensive guide to …, 2016 - Springer
Radioiodine imaging is an important diagnostic modality for the evaluation of differentiated
thyroid carcinoma. A basic understanding of the physics, radioisotopes, equipment, and …
thyroid carcinoma. A basic understanding of the physics, radioisotopes, equipment, and …